Therapeutic activation of p53 could offer new treatment option for salivary gland cancer

Professional, doctor. Scientist with microscope

Researchers at the University of Michigan Rogel Cancer Center and School of Dentistry found that certain drugs can change the fundamental makeup of cancer stem cells in mouse models of mucoepidermoid carcinoma – a lethal form of salivary gland cancer that currently has no treatment options.

Research illuminates approaches for long-term hearing loss treatment

Previous article

Discovery of a cellular uptake pathway for larger drug molecules

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News